Advantage of MIDAM Protocol in Treatment of Elderly Patients With Refractory and Relapsing Acute Myeloid LeukemiaFilanovsky · Journal of Clinical Oncology2010PDF49 KB
Outcome and impact of post‐remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemiaBahashwan · American Journal of Hematology2018PDF1.4 MB
Similarity of Fractionated Versus Single Dose(s) of Gemtuzumab Ozogamicin as Part of the MIDAM Salvage Regimen in Relapsed/refractory Acute Myeloid Leukemia PatientsPeterlin · Seminars in Hematology2016PDF307 KB
Assessing the Validity and Intra-observer Agreement of the MIDAM-LTC; an Instrument Measuring Factors That Influence Personal Dignity in Long-term Care FacilitiesOosterveld-Vlug · BioMed Central2014PDF203 KB
Can Personal Dignity Be Assessed by Others? A Survey Study Comparing Nursing Home Residents’ with Family Members’, Nurses’ and Physicians’ Answers on the MIDAM-LTCOosterveld-Vlug · International Journal of Nursing Studies2015PDF532 KB
Administration of Mylotarg 4 Days After Beginning of a Chemotherapy Including Intermediate-dose Aracytin and Mitoxantrone (MIDAM Regimen) Produces a High Rate of Complete Hematologic Remission in Patients with CD33+ Primary Resistant or Relapsed Acute Myeloid LeukemiaChevallier · Leukemia Research2005PDF69 KB
Strategic M&A: insights from Buffett's MidAmerican acquisitionCalandro · Strategy and Leadership2011PDF205 KB
Net Zero: Distributed Generation and FERC's MidAmerican DecisionFerrey · The Electricity Journal2004PDF256 KB
An Embedded Midamble Synchronization Approach for Generalized Frequency Division MultiplexingGaspar2015PDF168 KB
Investigation of a Copper-based Hoard from the Megalithic Site of al-Midamman, Yemen: an Interdisciplinary ApproachGiumlia-Mair · Journal of Archaeological Science2002PDF1.2 MB
African Market Women and Economic Power: The Role of Women in African Economic Developmentby Bessie House-Midamba; Felix K. EkechiParpart · Boston University African Studies Center1997PDF274 KB
